Universal-Beteiligungs- und Servicegesellschaft
APLS

Universal-Beteiligungs- und Servicegesellschaft’s Apellis Pharmaceuticals APLS Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,977
Closed -$281K – 2128
2026
Q1 		$281K Sell
6,977
-88,778
-93% -$1.91M ﹤0.01% 1885
2025
Q4 		$2.41M Buy
95,755
+49,642
+108% +$1.16M ﹤0.01% 1202
2025
Q3 		$1.04M Buy
46,113
+20,840
+82% +$486K ﹤0.01% 1534
2025
Q2 		$437K Buy
25,273
+9,114
+56% +$169K ﹤0.01% 1716
2025
Q1 		$353K Buy
+16,159
New +$446K ﹤0.01% 1742

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's APLS Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 6,977 shares — an estimated $281K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in APLS in Q1 2025 and held it in 5 quarters. The position peaked at $2.41M in Q4 2025. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 6,977 Apellis Pharmaceuticals shares in Q2 2026, an estimated $281K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Apellis Pharmaceuticals in Q1 2025 and held it in 5 quarters.
  • Universal-Beteiligungs- und Servicegesellschaft's Apellis Pharmaceuticals position peaked at $2.41M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.